LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing

Hamid Mehenni1, Nathalie Lin-Marq, Karine Buchet-Poyau

  • 1Département de Biologie Cellulaire, Université de Genève, 1211 Genève 4, Switzerland.

Insights

Germline mutations in the LKB1 gene cause Peutz-Jeghers syndrome (PJS). This study reveals PTEN interacts with LKB1, and disrupted interaction contributes to PJS and cancer predisposition.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Germline mutations in the LKB1 (STK11) tumor suppressor gene are linked to Peutz-Jeghers syndrome (PJS), a condition predisposing individuals to cancer.
  • LKB1, a serine/threonine kinase, is frequently inactivated in PJS patients.

Purpose of the Study:

  • To investigate the functional relationship between LKB1 and PTEN, a known tumor suppressor.
  • To determine if the interaction between LKB1 and PTEN is disrupted in Peutz-Jeghers syndrome.

Main Methods:

  • Protein-protein interaction assays to identify LKB1-interacting partners.
  • Analysis of LKB1 mutations found in PJS patients to assess their impact on PTEN interaction.
  • In vitro kinase assays to determine if PTEN is a substrate of LKB1.

Main Results:

  • The dual phosphatase and tumor suppressor PTEN was identified as an LKB1-interacting protein.
  • Several LKB1 point mutations associated with PJS were found to disrupt the interaction with PTEN.
  • PTEN was confirmed as a substrate of LKB1 kinase in vitro.
  • The interaction between PTEN and LKB1 promotes cytoplasmic relocalization of LKB1.

Conclusions:

  • The disruption of the LKB1-PTEN interaction may contribute to the pathogenesis of Peutz-Jeghers syndrome.
  • This study suggests a functional link between LKB1 and PTEN in hamartomatous polyposis syndromes.
  • LKB1 plays a crucial role as a tumor suppressor, particularly in the small intestine.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...